Company

Orano Med

Biotechnology Research Plano, Tx, United States 190 employees

Employees: 190
Contacts: 2
Emails: 2

www.oranomed.com LinkedIn

Orano Med Overview

Headquarters: Plano, Tx, United States
Website: www.oranomed.com
Industry: Biotechnology Research
Employees: 190
Founded: 2009
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Nuclear Medicine & Nuclear Industry Biotechnology Pharmaceutical Clinical Trial

About Orano Med

Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.

Orano Med Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Orano Med Org Chart

Sample employees and titles

Name	Title	Location	Contact
Frédéric Desdouits	CEO @ Treefrog Therapeutics		View
Pascal Mirocha	Senior Director Finance CFO	Greater Paris Metropolitan Region, France	Email
Anne-Sophie Bodin	VP, General Counsel, Competition	Greater Paris Metropolitan Region, France	Email
Olivier Nataf	Global Head of Oncology - Strategic		View